Table 1 Baseline characteristics in patients with Rheumatoid Arthritis
Statin non-user | Statin user | p | ASD | |
|---|---|---|---|---|
N | 25,764 | 25,764 | ||
Age group | 1.0000 | 0.00000 | ||
40–49 | 3095 (12.01%) | 3095 (12.01%) | ||
50–59 | 9485 (36.81%) | 9485 (36.81%) | ||
60–69 | 7469 (28.99%) | 7469 (28.99%) | ||
70–79 | 4462 (17.32%) | 4462 (17.32%) | ||
> =80 | 1253 (4.86%) | 1253 (4.86%) | ||
Sex | 1.0000 | 0.00000 | ||
Male | 7298 (28.33%) | 7298 (28.33%) | ||
Female | 18,466 (71.67%) | 18,466 (71.67%) | ||
Co-morbidities | ||||
Ischemic heart disease | 6668 (25.88%) | 8563 (33.24%) | <.0001 | 0.16184 |
Hypertension | 13,454 (52.22%) | 17,055 (66.20%) | <.0001 | 0.28735 |
Ischemic stroke | 3298 (12.80%) | 4531 (17.59%) | <.0001 | 0.13367 |
Diabetes mellitus | 7250 (28.14%) | 10,236 (39.73%) | <.0001 | 0.24653 |
Peptic ulcer | 12,575 (48.81%) | 12,110 (47.00%) | <.0001 | −0.03624 |
Co-medication | ||||
Aspirin | 3035 (11.78%) | 6587 (25.57%) | <.0001 | 0.35953 |
Beta- blockers | 5439 (21.11%) | 8076 (31.35%) | <.0001 | 0.23440 |
CCBs | 6820 (26.47%) | 9939 (38.58%) | <.0001 | 0.26060 |
ACEI | 2035 (7.90%) | 3607 (14.00%) | <.0001 | 0.19625 |
ARBs | 4060 (15.76%) | 7321 (28.42%) | <.0001 | 0.30876 |
Duration of RA (year) | 1.0000 | 0.00000 | ||
< 1 | 5402 (20.97%) | 5402 (20.97%) | ||
1–3 | 8018 (31.12%) | 8018 (31.12%) | ||
> 3 | 12,344 (47.91%) | 12,344 (47.91%) | ||